Piramal Pharma
PPLPHARMA · Pharma > Pharmaceuticals & Drugs Listing date: Oct. 19, 2022

Stock Price vs Company Growth
1d
1.3%
1w
0.5%
1m
4.3%
3m
24.1%
6m
53.2%
1y
9.1%
all
2.9%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 209 1.3%
167
232
Company Overview

Sales
9,205 Cr
Growth: 0.1%
Profit after Tax
-314 Cr
Growth: -9.5%
Mid Cap
27,838 Cr
P/S: 3.0x
Industry P/S: 2.9x
Fundamentals

Sales (Cr) ₹ 9,205
Growth 0.1%
EBITDA 11.0%
P/S 3.0x
Dividend 0.1%
P/E -87.5x
Book Value ₹ 60.8
PEG Ratio -1251.1x
ROE -3.9%
P/B 3.4x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company is one of the India’s largest Pharmaceutical Company. PPL offers a portfolio of differentiated products and services through its global development and manufacturing facilities and a global distribution network in various countries.
Investors (6)
Followers (2)